| Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats D Leo, I Sukhanov, F Zoratto, P Illiano, L Caffino, F Sanna, G Messa, ... Journal of Neuroscience 38 (8), 1959-1972, 2018 | 210 | 2018 |
| Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue-and schedule-induced reinstatement of nicotine self-administration behavior in rats AY Bespalov, OA Dravolina, I Sukhanov, E Zakharova, E Blokhina, ... Neuropharmacology 49, 167-178, 2005 | 153 | 2005 |
| TAAR1 modulates cortical glutamate NMDA receptor function S Espinoza, G Lignani, L Caffino, S Maggi, I Sukhanov, D Leo, L Mus, ... Neuropsychopharmacology 40 (9), 2217-2227, 2015 | 136 | 2015 |
| Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. M Pietraszek, I Sukhanov, P Maciejak, J Szyndler, A Gravius, A Wisłowska, ... European journal of pharmacology 514 (1), 25, 2005 | 125 | 2005 |
| Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1 S Espinoza, V Ghisi, M Emanuele, D Leo, I Sukhanov, TD Sotnikova, ... Neuropharmacology 93, 308-313, 2015 | 108 | 2015 |
| Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases MD Schwartz, JJ Canales, R Zucchi, S Espinoza, I Sukhanov, ... Expert opinion on therapeutic targets 22 (6), 513-526, 2018 | 67 | 2018 |
| Trace amine-associated receptor 5 provides olfactory input into limbic brain areas and modulates emotional behaviors and serotonin transmission S Espinoza, I Sukhanov, EV Efimova, A Kozlova, KA Antonova, P Illiano, ... Frontiers in molecular neuroscience 13, 18, 2020 | 61 | 2020 |
| Increased context-dependent conditioning to amphetamine in mice lacking TAAR1 I Sukhanov, L Caffino, EV Efimova, S Espinoza, TD Sotnikova, L Cervo, ... Pharmacological research 103, 206-214, 2016 | 47 | 2016 |
| TAAR1-dependent effects of apomorphine in mice I Sukhanov, S Espinoza, DS Yakovlev, MC Hoener, TD Sotnikova, ... International Journal of Neuropsychopharmacology 17 (10), 1683-1693, 2014 | 47 | 2014 |
| Trace amine-associated receptor 1 modulates the locomotor and sensitization effects of nicotine I Sukhanov, M Dorofeikova, A Dolgorukova, A Dorotenko, RR Gainetdinov Frontiers in pharmacology 9, 329, 2018 | 32 | 2018 |
| Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar− Kyoto and spontaneously hypertensive rats IM Sukhanov, ES Zakharova, W Danysz, AY Bespalov Behavioural pharmacology 15 (4), 263-271, 2004 | 32 | 2004 |
| Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats I Sukhanov, A Dorotenko, A Dolgorukova, MC Hoener, RR Gainetdinov, ... Neuropharmacology 144, 184-192, 2019 | 15 | 2019 |
| Novel translational rat models of dopamine transporter deficiency D Leo, I Sukhanov, RR Gainetdinov Neural Regeneration Research 13 (12), 2091-2093, 2018 | 15 | 2018 |
| The action of TAAR1 agonist RO5263397 on executive functions in rats A Dorotenko, M Tur, A Dolgorukova, N Bortnikov, IV Belozertseva, ... Cellular and Molecular Neurobiology 40 (2), 215-228, 2020 | 14 | 2020 |
| Unlocking the therapeutic potential of ulotaront as a trace amine-associated receptor 1 agonist for neuropsychiatric disorders SR Kuvarzin, I Sukhanov, K Onokhin, K Zakharov, RR Gainetdinov Biomedicines 11 (7), 1977, 2023 | 12 | 2023 |
| Dopamine transporter deficient rodents: perspectives and limitations for neuroscience A Savchenko, G Targa, Z Fesenko, D Leo, RR Gainetdinov, I Sukhanov Biomolecules 13 (5), 806, 2023 | 12 | 2023 |
| Discovery of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 2-(5-(4′-Chloro-[1,1′-biphenyl]-4-yl)-4H-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the … M Krasavin, A Lukin, I Sukhanov, AS Gerasimov, S Kuvarzin, EV Efimova, ... Biomolecules 12 (11), 1650, 2022 | 11 | 2022 |
| Behavioral effects of a potential novel TAAR1 antagonist VM Lam, CA Mielnik, C Baimel, P Beerepoot, S Espinoza, I Sukhanov, ... Frontiers in pharmacology 9, 953, 2018 | 11 | 2018 |
| Inhibition of PDE10A in a new rat model of severe dopamine depletion suggests new approach to non-dopamine Parkinson’s disease therapy I Sukhanov, A Dorotenko, Z Fesenko, A Savchenko, EV Efimova, MS Mor, ... Biomolecules 13 (1), 9, 2022 | 10 | 2022 |
| The lack of dopamine transporter is associated with conditional associative learning impairments and striatal proteomic changes A Savchenko, C Müller, J Lubec, D Leo, V Korz, L Afjehi-Sadat, ... Frontiers in psychiatry 13, 799433, 2022 | 10 | 2022 |
Raul R. GainetdinovInstitute of Translational Biomedicine St. Petersburg State UniversityE-mailová adresa ověřena na: spbu.ru
